医保药品准入谈判的"量价互换"机制探讨
Discussion on"Quantity-Price Tradeoff"Mechanism in the Negotiation of Medical Insurance Drug Access
陶立波 1王芳旭2
作者信息
- 1. 北京大学医学部卫生政策与技术评估中心 北京 100191;北京大学公共卫生学院 北京 100191
- 2. 北京大学医学部卫生政策与技术评估中心 北京 100191
- 折叠
摘要
目的:对我国医保药品准入谈判中量价互换的运行逻辑和实现条件进行分析和阐述.方法:基于管理学、经济学等相关学科理论,探讨市场运行中数量和价格的互动关系,结合医保药品准入谈判中量价关系的特点,阐述该项工作中量价互换政策意图的实现条件和机制,并对各种障碍因素的测量方法进行探讨.结论:医保准入谈判中的量价关系非常复杂,医保和厂商双方对后续运行的障碍要有清晰的认知,才能合理决策,推进该项工作顺利开展并惠及广大民众.
Abstract
Objective:The paper analyzed the operational logic and conditions for the quantity-price tradeoff in the negotiation of medical insurance drug access in China.Methods:Based on theories from management,economics,and related disciplines,this study explored the interactive relationship between quantity and price in market operations.It combined the characteristics of quantity-price relationships in the negotiation of medical insurance drug access to expound on the conditions and mechanisms for the realization of policy intentions in this work.It also discussed the measurement of various obstacles.Conclusions:The quantity-price relationship in the negotiation of medical insurance drug access is highly complex.Both the healthcare security departments and manufacturers need to have a clear understanding of the obstacles to subsequent operations,in order to make reasonable decisions,promote the smooth implementation of this work,and benefit the general public.
关键词
医保谈判/目录管理/量价互换Key words
medical insurance negotiation/catalogue management/quantity-price tradeoff引用本文复制引用
出版年
2024
NETL
NSTL
万方数据